// App-Quantinova.ai

13190 : Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation - a RE-LY Trial Analysis

Researchers

Presenter

  • Stefan H Hohnloser

Principal Investigators

  • Jonas Oldgren

  • Lars Wallentin

  • Ulrika Andersson

  • Stuart J Connolly

  • John W Eikelboom

  • Michael D Ezekowitz

  • Paul A Reilly

  • Agneta Siegbahn

  • Salim Yusuf

Medical Centers

  • Population Health Res Inst, Hamilton, ON, Canada

  • Uppsala Clinical Research Center, Uppsala, Sweden

  • Inc, Ridgefield, CT

  • Goethe University, Frankfurt, Germany

  • Thomas Jefferson Medical Coll and the Heart Ctr, Wynnewood, PA

Locations

  • United States

  • Canada

  • Germany

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Non-valvular atrial fibrillation

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Pradax

  • Warfarin

Outcome

  • N/A

Study Design

  • superiority

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved